142 related articles for article (PubMed ID: 6327965)
1. In vivo competition studies with analogues of 3-quinuclidinyl benzilate.
Eckelman WC; Grissom M; Conklin J; Rzeszotarski WJ; Gibson RE; Francis BE; Jagoda EM; Eng R; Reba RC
J Pharm Sci; 1984 Apr; 73(4):529-34. PubMed ID: 6327965
[TBL] [Abstract][Full Text] [Related]
2. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
Gibson RE; Eckelman WC; Vieras F; Reba RC
J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735
[TBL] [Abstract][Full Text] [Related]
3. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
[TBL] [Abstract][Full Text] [Related]
4. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
5. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer.
Eckelman WC; Eng R; Rzeszotarski WJ; Gibson RE; Francis B; Reba RC
J Nucl Med; 1985 Jun; 26(6):637-42. PubMed ID: 3998853
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
7. Binding of N-[propionyl-3H]propionylated alpha-bungarotoxin and L-[benzilic-4,4'-3H] quinuclidinyl benzilate to CNS extracts of the cockroach Periplaneta americana.
Lummis SC; Sattelle DB
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(1):75-83. PubMed ID: 2858352
[TBL] [Abstract][Full Text] [Related]
8. [125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors.
Gibson RE; Rzeszotarski WJ; Jagoda EM; Francis BE; Reba RC; Eckelman WC
Life Sci; 1984 Jun; 34(23):2287-96. PubMed ID: 6727565
[TBL] [Abstract][Full Text] [Related]
9. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
Pelham RW; Munsat TL
Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
[TBL] [Abstract][Full Text] [Related]
10. Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes.
Nagatomo T; Tsuchihashi H; Imai S
Jpn J Pharmacol; 1986 May; 41(1):135-8. PubMed ID: 3016391
[TBL] [Abstract][Full Text] [Related]
11. Quinuclidinyl benzilate binding in house fly heads and rat brain.
Jones SW; Sumikawa K
J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
Mittal CK
Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
[No Abstract] [Full Text] [Related]
13. [3H]Quinuclidinyl benzilate binding to muscarinic receptors and [3H]WB-4101 binding to alpha-adrenergic receptors in rabbit iris. Comparison of results in slices and microsomal fractions.
Taft WC; Abdel-Latif AA; Akhtar RA
Biochem Pharmacol; 1980 Oct; 29(20):2713-20. PubMed ID: 6108112
[No Abstract] [Full Text] [Related]
14. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the affinity constant of some muscarinic receptor antagonists with their displacement of [3H]quinuclidinyl benzilate binding in atrial and ileal longitudinal muscle of the guinea-pig.
Choo LK; Mitchelson FJ
J Pharm Pharmacol; 1985 Sep; 37(9):656-8. PubMed ID: 2867189
[TBL] [Abstract][Full Text] [Related]
16. Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding.
Morin AM; Wasterlain CG
Neurochem Res; 1980 Mar; 5(3):301-8. PubMed ID: 7374884
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
Aguilar JS; Salas PJ; De Robertis E
Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
[No Abstract] [Full Text] [Related]
18. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
20. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
